Bright Minds Biosciences Inc. · CSE:DRUG
Cormorant Asset Management, LP reported a 10.88% stake in Bright Minds Biosciences Inc. (Schedule 13G/A)
Event Jan 31, 2026 · Filed Feb 6, 2026
Cormorant Asset Management, LP reported a 10.88% stake in Bright Minds Biosciences Inc., 1,059,331 shares, as a passive investor on Jan 31, 2026. Filed Feb 6, 2026 (Schedule 13G/A).
- Stake
- 10.88%
- Shares
- 1,059,331
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Cormorant Asset Management, LP | 10.88% | 1,059,331 |
| Bihua Chen | 10.88% | 1,059,331 |
Source
Related
- Bright Minds Biosciences Inc.
- Cormorant Asset Management, LP
- Bright Minds Biosciences Inc. shareholders
- Schedule 13G/A · Cormorant Asset Management, LP · Aug 14, 2026
- Schedule 13G/A · Cormorant Asset Management, LP · Apr 30, 2026
- Schedule 13G/A · Adage Capital Management, L.P. · Aug 12, 2026
- Schedule 13D/A · Ian McDonald · Jul 2, 2026
- Schedule 13G · Vestal Point Capital, LP · May 15, 2026
- Schedule 13G/A · Janus Henderson Group PLC · May 15, 2026
- Schedule 13G/A · Janus Henderson Group PLC · May 15, 2026